Assertio Holdings Inc
ASRT0.720USD
+0.008+1.15%
收盤 12/19, 16:00（美東）報價延遲15分鐘
69.30M總市值
虧損本益比TTM
關於 Assertio Holdings Inc 公司
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
Assertio Holdings Inc簡介
公司代碼ASRT
公司名稱Assertio Holdings Inc
上市日期Feb 12, 1997
CEOReisenauer (Mark L)
員工數量58
證券類型Ordinary Share
年結日Feb 12
公司地址100 S. Saunders Road
城市LAKE FOREST
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編60045
電話12244197106
網址https://www.assertiotx.com/
公司代碼ASRT
上市日期Feb 12, 1997
CEOReisenauer (Mark L)
Assertio Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
98.54K
-8.33%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
53.75K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sigurd C. (Sig) Kirk
Mr. Sigurd C. (Sig) Kirk
Independent Director
Independent Director
--
--
Mr. Sravan K. Emany
Mr. Sravan K. Emany
Independent Director
Independent Director
--
--
Ms. Mary E Pietryga
Ms. Mary E Pietryga
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
98.54K
-8.33%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
53.75K
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
ROLVEDON
16.13M
55.19%
other
4.44M
15.20%
Sympazan
3.24M
11.10%
INDOCIN products
3.03M
10.38%
SPRIX Nasal Spray
1.98M
6.76%
Royalties and milestone revenue
400.00K
1.37%
地區USD
名稱
營收
佔比
United States
29.22M
100.00%
業務
地區
業務USD
名稱
營收
佔比
ROLVEDON
16.13M
55.19%
other
4.44M
15.20%
Sympazan
3.24M
11.10%
INDOCIN products
3.03M
10.38%
SPRIX Nasal Spray
1.98M
6.76%
Royalties and milestone revenue
400.00K
1.37%
股東統計
更新時間: 11月8日 週六
更新時間: 11月8日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
9.15%
The Vanguard Group, Inc.
4.60%
Renaissance Technologies LLC
3.06%
BlackRock Institutional Trust Company, N.A.
1.42%
Geode Capital Management, L.L.C.
1.06%
其他
80.71%
持股股東
持股股東
佔比
Nantahala Capital Management, LLC
9.15%
The Vanguard Group, Inc.
4.60%
Renaissance Technologies LLC
3.06%
BlackRock Institutional Trust Company, N.A.
1.42%
Geode Capital Management, L.L.C.
1.06%
其他
80.71%
股東類型
持股股東
佔比
Hedge Fund
14.41%
Investment Advisor
9.48%
Investment Advisor/Hedge Fund
3.17%
Individual Investor
2.60%
Research Firm
0.09%
其他
70.25%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
224
26.13M
41.62%
--
2025Q3
272
26.13M
50.34%
+166.65K
2025Q2
302
25.96M
57.74%
-170.79K
2025Q1
322
26.13M
60.78%
-32.08M
2024Q4
324
28.59M
62.27%
-1.80M
2024Q3
317
30.58M
67.93%
-6.52M
2024Q2
313
38.50M
75.68%
-8.13M
2024Q1
304
45.57M
70.80%
-21.77M
2023Q4
296
48.05M
61.35%
+410.44K
2023Q3
284
47.86M
41.05%
+12.38M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Nantahala Capital Management, LLC
8.81M
9.15%
+370.31K
+4.39%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
4.56%
--
--
Jun 30, 2025
Renaissance Technologies LLC
2.82M
2.93%
+117.69K
+4.35%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.37M
1.43%
-11.56K
-0.83%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.02M
1.06%
-86.31K
-7.79%
Jun 30, 2025
Two Sigma Investments, LP
867.90K
0.9%
-357.19K
-29.16%
Jun 30, 2025
CM Management, LLC
724.38K
0.75%
+249.38K
+52.50%
Jun 30, 2025
Polen Capital Management, LLC
651.61K
0.68%
-129.46K
-16.57%
Sep 30, 2024
Peisert (Daniel A)
607.46K
0.63%
--
--
Mar 13, 2025
Millennium Management LLC
694.52K
0.72%
-90.05K
-11.48%
Jun 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
ALPS Barron's 400 ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Royce Quant Small-Cap Quality Value ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Proshares Ultra Russell 2000
0%
Lattice Hartford Multifactor Small Cap ETF
0%
Fidelity Small-Mid Multifactor ETF
0%
iShares Russell 3000 ETF
0%
查看更多
ALPS Barron's 400 ETF
佔比0%
iShares Russell 2000 Value ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Royce Quant Small-Cap Quality Value ETF
佔比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
Lattice Hartford Multifactor Small Cap ETF
佔比0%
Fidelity Small-Mid Multifactor ETF
佔比0%
iShares Russell 3000 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
公告日期
類型
比率
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
May 17, 2021
Merger
4→1
常見問題
Assertio Holdings Inc的前五大股東是誰？
Assertio Holdings Inc的前五大股東如下：
Nantahala Capital Management, LLC持有股份：8.81M佔總股份比例：9.15%。
The Vanguard Group, Inc.持有股份：4.38M佔總股份比例：4.56%。
Renaissance Technologies LLC持有股份：2.82M佔總股份比例：2.93%。
BlackRock Institutional Trust Company, N.A.持有股份：1.37M佔總股份比例：1.43%。
Geode Capital Management, L.L.C.持有股份：1.02M佔總股份比例：1.06%。
Nantahala Capital Management, LLC持有股份：8.81M佔總股份比例：9.15%。
The Vanguard Group, Inc.持有股份：4.38M佔總股份比例：4.56%。
Renaissance Technologies LLC持有股份：2.82M佔總股份比例：2.93%。
BlackRock Institutional Trust Company, N.A.持有股份：1.37M佔總股份比例：1.43%。
Geode Capital Management, L.L.C.持有股份：1.02M佔總股份比例：1.06%。
Assertio Holdings Inc的前三大股東類型是什麼？
Assertio Holdings Inc 的前三大股東類型分別是：
Nantahala Capital Management, LLC
The Vanguard Group, Inc.
Renaissance Technologies LLC
Nantahala Capital Management, LLC
The Vanguard Group, Inc.
Renaissance Technologies LLC
有多少機構持有Assertio Holdings Inc(ASRT)的股份？
截至2025Q4，共有224家機構持有Assertio Holdings Inc的股份，合計持有的股份價值約為26.13M，占公司總股份的41.62% 。與2025Q3相比，機構持股有所增加，增幅為-8.72%。
哪個業務部門對Assertio Holdings Inc的收入貢獻最大？
在FY2025Q2，ROLVEDON業務部門對Assertio Holdings Inc的收入貢獻最大，創收16.13M，占總收入的55.19% 。
